ArticleFrontiers in immunology2025

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB-TACE combined with lenvatinib and camrelizumab.

Baiguo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.